1. Home
  2. TBPH vs AAT Comparison

TBPH vs AAT Comparison

Compare TBPH & AAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

N/A

Current Price

$19.26

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo American Assets Trust Inc.

AAT

American Assets Trust Inc.

N/A

Current Price

$19.81

Market Cap

1.1B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
TBPH
AAT
Founded
2013
1967
Country
United States
United States
Employees
N/A
208
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2013
2010

Fundamental Metrics

Financial Performance
Metric
TBPH
AAT
Price
$19.26
$19.81
Analyst Decision
Strong Buy
Hold
Analyst Count
5
2
Target Price
$27.80
$20.00
AVG Volume (30 Days)
386.5K
465.6K
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
6.91%
EPS Growth
N/A
N/A
EPS
0.88
0.92
Revenue
$15,386,000.00
$436,204,000.00
Revenue This Year
$70.90
$5.01
Revenue Next Year
N/A
N/A
P/E Ratio
$21.66
$21.39
Revenue Growth
N/A
N/A
52 Week Low
$7.90
$16.69
52 Week High
$21.03
$22.79

Technical Indicators

Market Signals
Indicator
TBPH
AAT
Relative Strength Index (RSI) 45.07 64.75
Support Level $18.27 $18.59
Resistance Level $19.04 $20.47
Average True Range (ATR) 0.91 0.41
MACD -0.09 0.13
Stochastic Oscillator 23.72 95.66

Price Performance

Historical Comparison
TBPH
AAT

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About AAT American Assets Trust Inc.

American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.

Share on Social Networks: